Lifecore Biomedical, Inc.
LFCR • NASDAQ • Stock Fundamentals
Lifecore Biomedical, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Paul Josephs, with a market cap of $211.9M.
Market Cap$211.9M
Employees459.0
CEOPaul Josephs
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 6, 2026 · 1 month 7 days agoQ1 2027
View reportNext EarningsAug 5, 2026 · in 2 monthsQ3 2026
Financials
Based on Q1 2027 filing
Lifecore Biomedical, Inc. FAQ
Common questions about Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. (LFCR) has a market capitalization of $211.9M and trades on NASDAQ.
Lifecore Biomedical, Inc. has approximately 459 employees.